Searchable abstracts of presentations at key conferences in endocrinology

ea0003p126 | Endocrine Tumours and Neoplasia | BES2002

Treatment options for refractory hypercalcaemia in a patient with PTHrP-secreting neuroendocrine tumour and primary hyperparathyroidism

Barakat M , Hameed A , Goodlad C , Tait P , Meeran K , Howard J , Williams G

A 47 year-old woman was referred with hypercalcaemia. She was receiving lithium, haloperidol and olanzapine for a schizo-affective disorder. Five years previously she had been diagnosed with liver metastases and a biopsy confirmed a neuroendocrine tumour. She had been told that her life-expectancy was limited, and she was discharged. Her calcium was 2.7mmol/l three years ago. At presentation to her local hospital, her calcium was >6.0mmol/l. She was treated aggressively wi...

ea0094op1.1 | Neuroendocrinology and Pituitary | SFEBES2023

Gene methylation status contributes to delayed puberty

Hall Charlotte L , Brempou Dimitria , Oakey Rebecca J. , Howard Sasha R.

Self-limited delayed puberty is a condition that is frequently familial with strong genetic determinants. It has been linked to coding region sequence variation by next generation sequencing of affected individuals, identifying genetic regulation of gonadotropin-releasing hormone (GnRH) pathways underlying this condition. However, the role of epigenetic modifiers of human pubertal timing is underexplored. The Hypothalamic-pituitary-gonadal (HPG) axis is unique as it is active ...